PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
60.05%
R&D change of 60.05% versus flat Healthcare spending. Walter Schloss would verify adequacy.
231.77%
G&A change of 231.77% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
121.69%
Operating expenses change of 121.69% versus flat Healthcare costs. Walter Schloss would verify control.
-100.00%
Total costs reduction while Healthcare median is -7.97%. Seth Klarman would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
D&A reduction while Healthcare median is -13.03%. Seth Klarman would investigate efficiency.
-127.89%
EBITDA decline while Healthcare median is -3.75%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-121.69%
Operating income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-17.94%
Other expenses reduction while Healthcare median is -4.80%. Seth Klarman would investigate advantages.
-139.60%
Pre-tax income decline while Healthcare median is -1.38%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-139.60%
Net income decline while Healthcare median is -1.51%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
-131.82%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-131.82%
Diluted EPS decline while Healthcare median is 0.64%. Seth Klarman would investigate causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.